Accelerated (9-mW/cm2) Corneal Collagen Crosslinking for Keratoconus—A 1-Year Follow-up
- 1 August 2014
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Cornea
- Vol. 33 (8), 769-773
- https://doi.org/10.1097/ico.0000000000000154
Abstract
Purpose: The aim of this study was to assess the efficacy of accelerated crosslinking (irradiance of 9 mW/cm2; 10 minutes) in keratoconus-affected eyes through topographical, visual, and refractive end points. Methods: Mild-moderate keratoconus-affected eyes that underwent accelerated corneal collagen crosslinking (CXL) treatment and had 6 and 12 months of follow-up were reviewed retrospectively. Data regarding uncorrected distance visual acuity (UDVA), manifest refraction, corrected distance visual acuity (CDVA), and computerized corneal topography data before surgery and post-CXL treatment were extracted and analyzed. Results: Sixteen eyes of 14 patients were included in the study. The mean patient age was 24.9 ± 5.8 years (range: 17.1–38.3 years). No statistically significant changes were found in the mean CDVA, mean refractive cylinder, or mean manifest refraction spherical equivalent at either time point. There was a gain of 0.13 logarithm of the minimum angle of resolution lines in the mean UDVA (P = 0.012) at 12 months. All corneal parameters including Ksteep, Kflat, average K (Km), corneal astigmatism (Kcyl), and maximal curvature reading at the corneal apex (Kmax) were stable at 6 and 12 months in all patients. No complications were observed during the follow-up period. Conclusions: Accelerated corneal CXL is effective in stabilizing topographic parameters after 12 months of follow-up in mild-moderate keratoconus-affected corneas. Improvement in the UDVA and stabilization of all tested corneal parameters were noted after the treatment. However, a longer follow-up with larger cohorts is necessary to validate these findings.Keywords
This publication has 22 references indexed in Scilit:
- Safety Profile of High-Fluence Corneal Collagen Cross-Linking for Progressive Keratoconus: Preliminary Results From a Prospective Cohort StudyJournal of Refractive Surgery, 2013
- Corneal Collagen Cross-linking with Riboflavin and Ultraviolet A Irradiation for KeratoconusOphthalmology, 2013
- Current status of corneal collagen cross‐linking for keratoconus: a reviewClinical and Experimental Optometry, 2013
- Corneal collagen cross-linking using riboflavin and ultraviolet A for the treatment of mild to moderate keratoconus: 2-year follow-upCanadian Journal of Ophthalmology, 2013
- Long-term Results of Riboflavin Ultraviolet A Corneal Collagen Cross-linking for Keratoconus in Italy: The Siena Eye Cross StudyAmerican Journal of Ophthalmology, 2010
- Collagen crosslinking with riboflavin and ultraviolet-A light in keratoconus: Long-term resultsJournal of Cataract & Refractive Surgery, 2008
- Safety of UVA-Riboflavin Cross-Linking of the CorneaCornea, 2007
- Corneal Endothelial Cytotoxicity of Riboflavin/UVA Treatment in vitroOphthalmic Research, 2003
- Endothelial cell damage after riboflavin–ultraviolet-A treatment in the rabbitJournal of Cataract & Refractive Surgery, 2003
- Riboflavin/ultraviolet-a–induced collagen crosslinking for the treatment of keratoconusAmerican Journal of Ophthalmology, 2003